First human test of NRS 033 begins: safety first in healthy volunteers
Knowledge-focused
Completed
This early-phase study tested a single dose of the experimental drug NRS 033 in 24 healthy adults aged 18 to 55. The main goal was to check for side effects and measure how the drug moves through the body. No treatment was given for any disease, so this study helps lay the ground…
Phase: PHASE1 • Sponsor: Nirsum Labs • Aim: Knowledge-focused
Last updated May 17, 2026 07:01 UTC